CFIm25 expression inhibition in glioblastoma cells enhances their tumorigenic properties, and increases tumor size, whereas CFIm25 overexpression reduces these properties and inhibits tumor growth [22]. The gene discussed is NUDT21; the disease is glioblastoma.